CLASS II Drug recall · Reported 5 Jan 2022 · FDA Enforcement Report
Norepinephrine 4 mg per (16 mcg per mL) in 5% Dextrose Injection recalled
SterRx is recalling Norepinephrine 4 mg per (16 mcg per mL) in 5% Dextrose Injection, distributed nationwide in the US. The recall was initiated on 12 Nov 2021 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0303-2022
- FDA event ID
- 89059
- Recalling firm
- SterRx, Plattsburgh, NY
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 12 Nov 2021
- FDA classified
- 29 Dec 2021
- Reported
- 5 Jan 2022
- Type
- Voluntary: Firm initiated
- Customers notified by
- Press Release
- Reason category
- Sterility
- Drug class
- Allergy Medication
Timeline
| 12 Nov 2021 | Recall initiated by company | |
| 29 Dec 2021 | Classified by FDA | +47 days |
| 5 Jan 2022 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Assurance of Sterility
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
NOREPINEPHRINE 4 mg per 250 mL (16 mcg per mL) in 5% Dextrose Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-451-01.
Where it was distributed
U.S.A. Nationwide
Questions about this recall
Is Norepinephrine 4 mg per (16 mcg per mL) in 5% Dextrose Injection recalled?
Yes. SterRx recalled Norepinephrine 4 mg per (16 mcg per mL) in 5% Dextrose Injection on 12 Nov 2021. The recall is Class II and its status is Terminated. Recall number D-0303-2022.
Why was it recalled?
Lack of Assurance of Sterility
Which lots are affected?
S21192/BUV 18-Apr-22 S21205/BVH 23-Apr-22 S21402/CCK 21-Aug-22
Where was it sold?
U.S.A. Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from SterRx
All 35| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Norepinephrine 32 mg per (128 mcg per mL) recalled by SterRx | SterRx | Sterility | Nationwide |
| Drug | CLASS II | Norepinephrine 8 mg per (32 mcg per mL) recalled by SterRx | SterRx | Sterility | Nationwide |
| Drug | CLASS II | Norepinephrine 16 mg per (64 mcg per mL) recalled by SterRx | SterRx | Sterility | Nationwide |
| Drug | CLASS II | Sodium Bicarbonate in 5% Dextrose Injection recalled by SterRx | SterRx | Sterility | Nationwide |
| Drug | CLASS II | Norepinephrine 4 mg per (16 mcg per mL) recalled by SterRx | SterRx | Sterility | Nationwide |